Louise Ainley

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Immune clues to infection risk in myeloma
  Blood 2026 DOI: 10.1182/blood.2026033248
  +Save
• Tumour-intrinsic features shape T-cell differentiation through myeloma disease evolution
  2024 DOI: 10.1101/2024.06.22.24309250
  +Save
• Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression
  British Journal of Haematology 2022 DOI: 10.1111/bjh.17969
  +Save
• Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors
  British Journal of Haematology 2022 DOI: 10.1111/bjh.17864
  +Save
• Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy
  British Journal of Haematology 2021 DOI: 10.1111/bjh.17441
  +Save
• DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation
  British Journal of Haematology 2021 DOI: 10.1111/bjh.17248
  +Save